OSIC Benefits

for PATIENTS

Earlier diagnosis, individual prognosis and access to more effective disease management

for RADIOLOGISTS

Improved decision support tools

for HEALTHCARE SYSTEMS

Support in delivering improved care and better outcomes for patients

for PHARMACEUTICAL COMPANIES

Improved efficiency in developing new medications for ILDs

for MEDICAL TECHNOLOGY VENDORS

Ability to incorporate biomarker analysis tools into products — a potential differentiator

for ACADEMIC INSTITUTIONS

Enhance current research projects and magnify contributions designed to contribute to the fight against IPF and other ILDs

First steps to becoming a member

Additional member partners, collaborators and contributors are welcome and encouraged.

Get Started